Interactions of antithyroid drugs and their analogues with halogens and their biological implications

Roy, Gouriprasanna ; Bhabak, Krishna P. ; Mugesh, Govindasamy (2011) Interactions of antithyroid drugs and their analogues with halogens and their biological implications Crystal Growth & Design, 11 (6). pp. 2279-2286. ISSN 1528-7483

Full text not available from this repository.

Official URL: http://pubs.acs.org/doi/abs/10.1021/cg101688v

Related URL: http://dx.doi.org/10.1021/cg101688v

Abstract

The selenium analogue of antithyroid drug methimazole (MSeI) reacts with molecular bromine to produce two different types of novel complexes depending upon the molar ratio of MSeI to Br2 in the reaction medium. Dicationic diselenide complex with two Br- ions as counterions is produced in the reaction of MSeI with 0.5 equiv of Br2 (MSeI/Br2, 1.0:0.5), whereas a stable 10-Se-3 hypervalent "T-shaped" complex featuring a linear Br-Se-Br moiety was produced when MSeI was treated with Br2 in an equimolar ratio (MSeI/Br2, 1.0:1.0). A substitution at the free N-H group in MSeI alters its reactivity toward iodine/bromine. For example, the N,N-disubstituted selones exclusively produce the corresponding 10-Se-3 hypervalent "T-shaped" complexes in the reaction with I2. In the presence of the lectoperoxidase/H2O2/I- system, N,N-dimethylimidazole-2-selone produces the corresponding dicationic diselenide with two I- counterions as the final metabolite. The formation of ionic species in these reactions is confirmed by single crystal X-ray diffraction studies and in some cases by Fourier transform-Raman spectroscopic investigations.

Item Type:Article
Source:Copyright of this article belongs to American Chemical Society.
ID Code:79287
Deposited On:25 Jan 2012 06:37
Last Modified:25 Jan 2012 06:37

Repository Staff Only: item control page